Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation
-
Published:2024-02
Issue:2
Volume:90
Page:408-410
-
ISSN:0190-9622
-
Container-title:Journal of the American Academy of Dermatology
-
language:en
-
Short-container-title:Journal of the American Academy of Dermatology
Author:
Hackley Madison, Thampy Daphne, Waseh Shayan, Feldman Steven R., Blauvelt Andrew, Weinberg Jeffrey M., Schwartzman Sergio, Liao Wilson, Prussick Ronald, Cohen Jeffrey M., Hsu SylviaORCID, Gladman Dafna D., Reddy Soumya, Merola Joseph, Calabrese Cassandra, Lebwohl Mark, Kindred Chesahna, Miller Lauren, Kircik Leon, Liu Clive, Lewitt G. Michael, Lee Lara Wine, Desai Seemal, Van Voorhees Abby, Glick Brad P., Soung Jennifer
Reference5 articles.
1. Mortality in generalized pustular psoriasis: a population-based national register study;Ericson;J Am Acad Dermatol,2023 2. Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan;Miyachi;J Am Acad Dermatol,2022 3. Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment;Rivera-Díaz;Dermatol Ther (Heidelb),2023 4. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia;Choon;Int J Dermatol,2014 5. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity;Mirzazadeh;PLoS One,2021
|
|